Improving the earlier detection
of aggressive prostate cancer with our Precision Prostate Cancer Pathway

Our prostate cancer pathway allows for confident decision-making between you and your patient by enhancing the current standard of care. Click above to download our pathway brochure to learn more about the three biomarker tests to improve patient care.



A tissue test to improve the identification of men at risk for undetected clinically significant prostate cancer after a negative biopsy.

Localized Prostate Cancer

A genomic assay designed for men with low-, intermediate-, and high-risk localized prostate cancer to help guide treatment decisions at the time of diagnosis.



A highly predictive urine test to help identify men at risk for aggressive prostate cancer prior to initial biopsy.